Weekly Digest – June 2024 Weekly Digest – June 2024 11 June 2024: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates France-based biopharmaceutical company Adcytherix has launched with seed funding of €30m ($32.2m) […]
Weekly Digest – June 2024 Weekly Digest – June 2024 12 June 2024: OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy OBI Pharma has initiated a Phase 1/2 clinical trial for […]
Weekly Digest – June 2024 Weekly Digest – June 2024 13 June 2024: Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 as Monotherapy for Advanced Pancreatic Cancer Innovent Biologics secured Fast Track Designation from the U.S. FDA […]
